Odile Rundquist

Odile Rundquist, PhD, currently serves as a Partner at Bioqube Ventures and an Evaluation Board Member at Wyss Zurich, both established in October 2023 and December 2022, respectively. With over 15 years of experience in the pharmaceutical sector, Odile has held roles such as Scientific Advisor at Bootstrap Europe and Board Member at Timeline® and Vandria SA. Previous positions include Senior Scientific Advisor at Family Office - Massellaz AG and Advisory Board Member at the Center for Sustainable Finance and Private Wealth Singapore. A seasoned analyst, Odile worked as a Senior Pharmaceutical Analyst at Helvea SA and as a Pharmaceutical Sell-Side Analyst at Vontobel, focusing on major European pharmaceutical companies. Education credentials include a PhD in Biochemistry from Medical Centre University, Geneva, and additional qualifications from Scripps Research and Université de Fribourg.